VIRVir Biotechnology, Inc.

$11.10

Is the business good?

How good a business is VIR?

Share count, year on year
+7.2%

Share count, year on year · shareholders own a smaller slice than a year ago

Operating margin by fiscal year
YearOperating margin
FY2020−389%
FY202138%
FY202252%
FY2023−794%
FY2024−791%
FY2025−699%
Details
Free cash flow, trailing twelve months
−$450M
Net income, trailing twelve months
−$443M

Margins, capital and share counts from the statements as filed with the SEC; cash conversion from the cash flow statement.